The Predictors for Twelve Months Efficacy of Denosumab, an Anti­RANKL Antibody, on Osteoporosis in Rheumatoid Arthritis Patients from Japanese Multicenter Study (TBCR­BONE)
The Predictors for Twelve Months Efficacy of Denosumab, an Anti­RANKL Antibody, on Osteoporosis in Rheumatoid Arthritis Patients from Japanese Multicenter Study (TBCR­BONE)
复制标题
抗地诺单抗 12 个月疗效的预测因子
DOI：
--
复制
发表时间：
2016
期刊：
影响因子：
--
通讯作者：
on behalf of TBCR-BONE
中科院分区：
文献类型：
--
作者：
Y. Hirano;Y. Kanayama;M. Isono;N. Ishiguro;T. Kojima;on behalf of TBCR-BONE
